Merck Total Current Liabilities 2010-2024 | MKKGY
Merck total current liabilities from 2010 to 2024. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
- Merck total current liabilities for the quarter ending June 30, 2024 were $10.695B, a 10.88% increase year-over-year.
- Merck total current liabilities for 2023 were $9.415B, a 6.07% decline from 2022.
- Merck total current liabilities for 2022 were $10.023B, a 18.79% decline from 2021.
- Merck total current liabilities for 2021 were $12.342B, a 17.05% increase from 2020.
Merck Annual Total Current Liabilities
(Millions of US $) |
| 2023 |
$9,415 |
| 2022 |
$10,023 |
| 2021 |
$12,342 |
| 2020 |
$10,545 |
| 2019 |
$13,263 |
| 2018 |
$10,059 |
| 2017 |
$9,760 |
| 2016 |
$10,055 |
| 2015 |
$10,412 |
| 2014 |
$8,775 |
| 2013 |
$5,179 |
| 2012 |
$5,867 |
| 2011 |
$6,077 |
| 2010 |
$ |
| 2009 |
$ |
Merck Quarterly Total Current Liabilities
(Millions of US $) |
| 2024-06-30 |
$10,695 |
| 2024-03-31 |
$10,791 |
| 2023-12-31 |
$9,415 |
| 2023-09-30 |
$9,453 |
| 2023-06-30 |
$9,646 |
| 2023-03-31 |
$10,257 |
| 2022-12-31 |
$10,023 |
| 2022-09-30 |
$9,480 |
| 2022-06-30 |
$10,342 |
| 2022-03-31 |
$11,454 |
| 2021-12-31 |
$12,342 |
| 2021-09-30 |
$11,548 |
| 2021-06-30 |
$11,832 |
| 2021-03-31 |
$12,842 |
| 2020-12-31 |
$10,545 |
| 2020-09-30 |
$11,350 |
| 2020-06-30 |
$11,099 |
| 2020-03-31 |
$11,875 |
| 2019-12-31 |
$13,263 |
| 2019-09-30 |
$10,736 |
| 2019-06-30 |
$11,796 |
| 2019-03-31 |
$12,714 |
| 2018-12-31 |
$10,059 |
| 2018-09-30 |
$10,425 |
| 2018-06-30 |
$9,859 |
| 2018-03-31 |
$10,489 |
| 2017-12-31 |
$9,760 |
| 2017-09-30 |
$9,614 |
| 2017-06-30 |
$9,823 |
| 2017-03-31 |
$9,942 |
| 2016-12-31 |
$10,055 |
| 2016-09-30 |
$9,498 |
| 2016-06-30 |
$9,506 |
| 2016-03-31 |
$9,967 |
| 2015-12-31 |
$10,412 |
| 2015-09-30 |
$5,860 |
| 2015-06-30 |
$5,881 |
| 2015-03-31 |
$5,997 |
| 2014-12-31 |
$8,775 |
| 2014-09-30 |
$7,733 |
| 2014-06-30 |
$7,065 |
| 2014-03-31 |
$7,008 |
| 2013-12-31 |
$5,179 |
| 2013-09-30 |
$5,404 |
| 2013-06-30 |
$5,869 |
| 2013-03-31 |
$6,103 |
| 2012-12-31 |
$5,867 |
| 2012-09-30 |
$6,252 |
| 2012-06-30 |
$5,055 |
| 2012-03-31 |
|
| 2011-12-31 |
$6,077 |
| 2011-09-30 |
|
| 2011-06-30 |
$5,115 |
| 2011-03-31 |
|
| 2010-12-31 |
|
| 2010-09-30 |
$4,969 |
| 2010-06-30 |
|
| 2010-03-31 |
|
| 2009-12-31 |
|
| 2009-09-30 |
|
| 2009-06-30 |
|
| 2009-03-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$21.306B |
$22.719B |
|
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
|
